FDA Approves Wider Use Of Breast Cancer Drug
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
195956
A newer drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors said Wednesday, citing a new study.
304755
TORONTO - A standard treatment used to prevent the recurrence of breast cancer should be replaced by a newer drug, according to a study released Wednesday.
745892
Sanofi-Aventis said on Friday that  U.S. regulators had approved wider use for its colon cancer  drug Eloxatin, lifting shares in the world's third-largest  pharmaceuticals group.
310366
San Antonio - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
442676
(National-NBC) Nov. 30, 2004 - A medicine used to make a woman&#39;s bones stronger may also cut the risk of breast cancer in half.
399636
A drug currently used against advanced breast cancer may provide better protection against recurrence or spreading than standard medication for post-menopausal women who have been treated for early forms of the disease, Swiss pharmaceutical giant Novartis AG and independent researchers said Wednesday.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
329902
A new drug may give older women with early stages of breast cancer a better chance of beating the disease and stopping it returning and spreading.
477676
The drug toremifene, used to treat breast cancer in women, has been found to also reduce the incidence of prostate cancer in men at risk for the disease.
208946
The Food and Drug Administration agreed Friday to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
202457
Older women with breast cancer are being encouraged to use a new drug which is better at preventing re-occurrence of the disease, has fewer side effects - but costs Â£1,000 a year instead of Â£30.
112717
The US Food and Drug Administration Friday said it had approved Tarceva (erlotinib) tablets for patients with metastatic lung cancer.
251574
U.S. health regulators have approved GlaxoSmithKline Plc's   pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.